Palette Life Sciences
About Palette Life Sciences
Palette Life Sciences is a fully integrated life sciences company. Palette Life Sciences’ products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Deflux®, Barrigel®, Solesta®, and Lidbree™. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life.
Company Metrics
- Employees:
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 70000000 USD
- Last Funding: 40000000 USD (Debt Financing)
- Funding Status:
Technology Stack
Palette Life Sciences actively uses None products in their tech stack.
Market Presence
Industries: Health Care, Life Science, Therapeutics
Headquarters: Santa Barbara, California, United States
Leadership
Employees
- Ole Mikkelsen - Chief Operating Officer (LinkedIn)
- Travis Gay - Chief Commercial Officer (CCO) (LinkedIn)